Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS).
Authors:
- R J BiggarRBR J Biggar
- M MelbyeMMM Melbye
- P EbbesenPEP Ebbesen
- S AlexanderSAS Alexander
- J O NielsenJNJ O Nielsen
- P SarinPSP Sarin
- V FaberVFV Faber
Abstract
Western blot analysis was used to document the development and changes in human T lymphotropic virus III (HTLV-III) antibody among Danish homosexual men followed longitudinally over three years. Reactivity against p15, p24, and p55 appeared earliest. After seroconversion the antibody concentration fluctuated, but in one instance a steady decline in banding intensity was seen during the 18 months before onset of the acquired immune deficiency syndrome (AIDS) and throughout the remaining eight months of his life.Keywords
This publication has 5 references indexed in Scilit:
- Antibodies to HTLV-III in Swiss Patients with AIDS and Pre-AIDS and in Groups at Risk for AIDSNew England Journal of Medicine, 1985
- Screening Test for HTLV-III (AIDS Agent) AntibodiesJAMA, 1985
- Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applicationsJAMA, 1985
- Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.BMJ, 1984
- THE NEUROPATHOLOGY OF ACQUIRED IMMUNE-DEFICIENCY SYNDROME1984